Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study
Authors Bisht B, Darling W, Shivapour ET, Lutgendorf S, Snetselaar L, Chenard C, Wahls T
Received 28 October 2014
Accepted for publication 9 December 2014
Published 27 February 2015 Volume 2015:5 Pages 19—35
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Thomas Müller
Babita Bisht,1 Warren G Darling,2 E Torage Shivapour,3 Susan K Lutgendorf,4–6 Linda G Snetselaar,7 Catherine A Chenard,1 Terry L Wahls1,8
1Department of Internal Medicine, Carver College of Medicine, University of Iowa, 2Department of Health and Human Physiology, College of Liberal Arts and Sciences, University of Iowa, 3Department of Neurology, Carver College of Medicine, University of Iowa, 4Department of Psychology, College of Liberal Arts and Sciences, University of Iowa, 5Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa, 6Department of Urology, Carver College of Medicine, University of Iowa, 7Department of Epidemiology, College of Public Health, University of Iowa, 8Department of Internal Medicine, VA Medical Center, Iowa City, IA, USA
Background: Fatigue is a disabling symptom of multiple sclerosis (MS) and reduces quality of life. The aim of this study was to investigate the effects of a multimodal intervention, including a modified Paleolithic diet, nutritional supplements, stretching, strengthening exercises with electrical stimulation of trunk and lower limb muscles, and stress management on perceived fatigue and quality of life of persons with progressive MS.
Methods: Twenty subjects with progressive MS and average Expanded Disability Status Scale (EDSS) score of 6.2 (range: 3.5–8.0) participated in the 12-month phase of the study. Assessments were completed at baseline and at 3 months, 6 months, 9 months, and 12 months. Safety analyses were based on monthly side effects questionnaires and blood analyses at 1 month, 3 months, 6 months, 9 months, and 12 months.
Results: Subjects showed good adherence (assessed from subjects' daily logs) with this intervention and did not report any serious side effects. Fatigue Severity Scale (FSS) and Performance Scales-fatigue subscale scores decreased in 12 months (P<0.0005). Average FSS scores of eleven subjects showed clinically significant reduction (more than two points, high response) at 3 months, and this improvement was sustained until 12 months. Remaining subjects (n=9, low responders) either showed inconsistent or less than one point decrease in average FSS scores in the 12 months. Energy and general health scores of RAND 36-item Health Survey (Short Form-36) increased during the study (P<0.05). Decrease in FSS scores during the 12 months was associated with shorter disease duration (r=0.511, P=0.011), and lower baseline Patient Determined Disease Steps score (rs=0.563, P=0.005) and EDSS scores (rs=0.501, P=0.012). Compared to low responders, high responders had lower level of physical disability (P<0.05) and lower intake of gluten, dairy products, and eggs (P=0.036) at baseline. High responders undertook longer duration of massage and stretches per muscle (P<0.05) in 12 months.
Conclusion: A multimodal intervention may reduce fatigue and improve quality of life of subjects with progressive MS. Larger randomized controlled trials with blinded raters are needed to prove efficacy of this intervention on MS-related fatigue.
Keywords: modified Paleolithic diet, exercise, neuromuscular electrical stimulation, stress management, lifestyle changes, vitamins, supplements
Corrigendum for this paper has been published
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]